David H. Jelley

Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial

Lori M. Laffel, Thomas Danne, Georgeanna J. Klingensmith et al. · The Lancet Diabetes & Endocrinology · 2023 · 98 citations · Full text

Metabolic Syndrome, Diabetes Management, Young People +11

Effect of Newborn Screening for Congenital Adrenal Hyperplasia

Patrick G. Brosnan, Christine A. Brosnan, Stephen F. Kemp et al. · Archives of Pediatrics and Adolescent Medicine · 1999 · 88 citations

Misdiagnosis and Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes: Patient and Caregiver Perspectives

Cynthia Muñoz, Anna Floreen, Colleen Garey et al. · Clinical Diabetes · 2019 · 88 citations · Full text

The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange

Kara Mizokami‐Stout, Zoey Li, Nicole C. Foster et al. · Diabetes Care · 2020 · 84 citations · Full text

Congenital Hypothyroidism: Screening and Management

Susan R. Rose, Ari J. Wassner, Kupper A. Wintergerst et al. · PEDIATRICS · 2022 · 68 citations

Clinical Symptoms, Neonatology, Thyroid Function Testing +13